Navigating the complex landscape of legal sourcing for controlled substances, specifically Schedule I drugs, represents a particularly unique area for licensed Québécois institutions—typically research facilities—and demands meticulous adherence to stringent regulations. The process goes far beyond standard vendor selection, encompassing deta